Arushi Khurana, MBBS¹, Raphael Mwangi, M.S.^2*, James R. Cerhan, MD, PhD³, Jonathon B. Cohen, MD, MS⁴, Jennifer R. Chapman-Fredricks, MD^5*, Jonathan W. Friedberg, MD, MMSc⁶, Christopher R. Flowers, MD, MS⁷, Richard Burack, MD, PhD⁸, Izidore S. Lossos, MD⁹, Loretta J. Nastoupil, MD¹⁰, Andrew L. Feldman, MD¹¹, Brad S. Kahl, MD¹², Peter Martin, MD¹³, Grzegorz S. Nowakowski, MD¹⁴, Brian K. Link, MD^15*, Timothy J. McDonnell, MD, PhD^16*, Giorgio Inghirami, MD^17*, Sergei Syrbu, MD, PhD^18*, Kiran R. Vij¹⁹, Matthew J. Maurer, DSc³, Thomas M. Habermann, MD¹⁴ and Rebecca L. King, MD¹¹

¹Mayo Clinic, Rochester, MN
²Department of Health Sciences Research, Mayo Clinic, Rochester, MN
³Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁴Winship Cancer Institute, Emory University, Atlanta, GA
⁵Department of Pathology and Laboratory Medicine, University of Miami, Miami, FL
⁶Wilmot Cancer Center, University of Rochester, Rochester, NY
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY
⁹Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL
¹⁰MD Anderson Cancer Center, Houston, TX
¹¹Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
¹²Siteman Cancer Center, Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
¹³Weill Cornell Medical College, New York, NY
¹⁴Division of Hematology, Mayo Clinic, Rochester, MN
¹⁵Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
¹⁶UT M.D. Anderson Cancer Center, Houston, TX
¹⁷Weill Cornell Medicine, New York, NY
¹⁸University of Iowa, Iowa City, IA
¹⁹Washington University School of Medicine, Saint Louis, MO

Steven M. Bair, MD¹, Mayur Narkhede, MD^2*, Zachary AK Frosch, MD, MSHP³, Elise A. Chong, MD⁴, Daniel A. Ermann, MD⁵, Iris Isufi⁶, Farrukh T. Awan, MD⁷, Julio C Chavez, MD⁸, Grace N Bosma, MS^9* and Diana Abbott, PhD¹⁰

¹Division of Hematology, University of Colorado - Anschutz Medical Campus, Aurora, CO
²University of Alabama at Birmingham, Birmingham, AL
³Department of Hematology/Oncology; Cancer Prevention and Control Research Program, Fox Chase Cancer Center, Philadelphia, PA
⁴Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁵Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁶Yale University School of Medicine, New Haven, CT
⁷Division of Hematologic Malignancies, UT Southwestern Medical Center, Dallas, TX
⁸Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁹Division of Hematology, University of Colorado School of Medicine, Aurora, CO
¹⁰University of Colorado, Aurora, CO

Brian J. Sworder, MD, PhD¹, Sang Eun Yoon, MD^2*, Seok Jin Kim, MD, PhD^3,4, Andre Schultz, PhD^5*, Gregory Hogan, PhD^5*, Sandra Close, PhD^5*, Jacob J. Chabon, PhD^5*, Maximilian Diehn, MD, PhD^6*, David M. Kurtz, MD, PhD⁷, Ash A. Alizadeh, MD, PhD^7,8 and Won Seog Kim, MD, PhD^9*

¹University of California, Irvine, Irvine, CA
²Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
³Samsung Med. Ctr., Seoul, KOR
⁴Samsung Med. Ctr., Seoul, Korea, Republic of (South)
⁵Foresight Diagnostics, Aurora, CO
⁶Department of Radiation Oncology, Stanford University, Stanford, CA
⁷Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
⁸Stanford Cancer Institute, Stanford University, Stanford, CA
⁹Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)

Pallawi Torka¹, Esther Drill, DrPH^2*, Nivetha Ganesan^3*, Mayan Oliveros^4*, Alexander P. Boardman^5*, Philip Caron, MD⁶, Kevin A. David, MD^7*, Zachary D. Epstein-Peterson, MD⁶, Lorenzo Falchi, MD⁵, Paola Ghione, MD, MSEpi³, Steven M. Horwitz, MD³, Andrew M. Intlekofer, MD, DPhil⁶, William Johnson^3*, Anita Kumar, MD⁸, Jennifer Kimberly Lue, MD⁶, Alison Moskowitz, MD³, Ariela Noy, MD⁷, Colette Owens, MD⁶, Maria Lia Palomba, MD⁷, Robert Stuver, MD³, Santosha A Vardhana, MD, PhD^7*, Andrew D. Zelenetz, MD, PhD⁶, Gilles Salles, MD, PhD⁷ and Paul A. Hamlin, MD⁶

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, Montvale, NJ
²Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Memorial Sloan Kettering Cancer Center, New York
⁵Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
⁸Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ

Fabian Frontzek^1,2*, Loïc Renaud, MD^3*, Ulrich Duehrsen, MD^4*, Viola Poeschel, MD^5*, Sophie Bernard^6*, Loïc Chartier^7*, Nicolas Ketterer, MD^8*, Christian Recher, MD, PhD^9*, Olivier Fitoussi^10*, Gerhard Held, MD^11*, Rene-Olivier Casasnovas, MD^12*, Corinne Haioun, MD, PhD¹³, Nicolas Mounier^14*, Hervé Tilly, MD, PhD¹⁵, Franck Morschhauser, MD PhD¹⁶, Steven Le Gouill, MD, PhD¹⁷, Imke E. Karsten^2*, Gerben Duns, PhD^18*, Christian Steidl, MD, PhD¹⁹, David W. Scott, MBChB, PhD²⁰, Wolfram Klapper^21*, Andreas Rosenwald, MD^22*, German Ott, MD^23*, Thierry Jo Molina, MD, PhD^24*, Georg Lenz²⁵, Marita Ziepert, PhD^26*, Bettina Altmann, PhD^26*, Catherine Thieblemont, MD^27* and Norbert Schmitz, MD^28*

¹Department of Lymphoid Cancer Research, BC Cancer Research Centre, Vancouver, BC, Canada
²Department of Medicine A, University Hospital Muenster, Muenster, Germany
³Gustave Roussy, Paris, France
⁴Universitaetsklinikum Essen, Klinik Fuer Haematologie, Essen, DEU
⁵Saarland University Medical School, Homburg/Saar, Germany
⁶Service Hématologie, Centre hospitaliser de la côte basque, Bayonne, France
⁷LYSARC, Pierre Bénite, France
⁸Clinique Bois-Cerf, Lausanne, CHE
⁹Service d'Hématologie, Centre Hospitalo-universitaire de Toulouse, Centre de Recherches en Cancérologie de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Université de Toulouse, UPS, INSERM, CNRS, Toulouse, France, Toulouse, France
¹⁰Oncologie-Hematologie, Polyclinique Bordeaux Nord Aquitaine, Bordeaux, FRA
¹¹Department of Internal Medicine 1, Westpfalz-Klinikum, Kaiserslautern, Germany
¹²CHU DE DIJON - HÔPITAL F. MITTERRAND, Dijon, FRA
¹³Lymphoid Malignancies Department, Henri Mondor University Hospital, AP-HP, Créteil, France
¹⁴CHU De Nice, Hôpital De L Archet, Nice, France
¹⁵Centre Henri-Becquerel and University of Rouen, Rouen, France
¹⁶Hematology Department, Centre Hospitalier Régional Universitaire de Lille, Lille, AL, France
¹⁷Hematology Department, Institut Curie, Paris, France
¹⁸BC Cancer, Vancouver, BC, Canada
¹⁹Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
²⁰Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
²¹Department of Pathology, University Hospital Schleswig-Holstein, Kiel, DEU
²²Institute of Pathology, Julius-Maximilians-Universität Würzburg, Wuerzburg, Germany
²³Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany
²⁴Necker enfants malades, APHP, Paris, Paris, FRA
²⁵University of Münster, Munster, Germany
²⁶Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig, Germany
²⁷Service d'hémato-oncologie, Hôpital Saint-Louis, Paris, France
²⁸University Hospital Münster, Münster, DEU

Valentin Letailleur^1*, Isabelle Chaillol^2*, Fanny Cherblanc, PhD^2*, Herve Ghesquieres, MD, PhD^3*, Frederic Peyrade, MD^4*, Fabrice Jardin, MD PhD^5*, Stephanie Guidez^6*, Fontanet Delices Bijou, MD⁷, Pierre Sesques^8*, Cédric Rossi, MD, PhD⁹, Luc Matthieu Fornecker^10*, Ludovic Fouillet, MD^11*, Sylvain Carras^12* and Benoit Tessoulin^1*

¹Hematology Department, CHU Nantes, Nantes, France
²Lymphoma Academic Research Organisation, Lyon, France
³Hematology Department, Hopital Lyon Sud - HCL, Lyon, France
⁴Centre Antoine-Lacassagne, Nice, FRA
⁵Centre Henri-Becquerel and University of Rouen, Rouen, France
⁶CHU de Poitiers, Poitiers, France
⁷Institut Bergonié, Merignac, FRA
⁸CHU LYON SUD, PIERRE BENITE CEDEX, France
⁹CHU Dijon, Dijon, France
¹⁰Hematology, ICANS, Strasbourg, FRA
¹¹Hematology department, CHU, Saint-Etienne, France
¹²Hematology, Univ. Grenoble Alpes. Institute For Advanced Biosciences (INSERM U1209, CNRS UMR 5309), University Hospital, La Tronche, France